EDITORIAL
Accepted on 31 Oct 2025
Editorial: Enhancing Therapeutic Strategies: A Focus on Pharmacovigilance in New Wave Antidepressants and Antipsychotics
- 397 views
- Frontiers in Psychiatry
- Psychopharmacology
- Research Topics
- Enhancing Therapeutic Strategies: A Focus on Pharmacovigilance in New Wave Antidepressants and Antipsychotics
Enhancing Therapeutic Strategies: A Focus on Pharmacovigilance in New Wave Antidepressants and Antipsychotics
4,441
Total downloads
23k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 17 Oct 2025
Investigating the mechanisms of Sini San in alleviating inflammatory responses via multi-omics and the BDNF/TrkB/PI3K/AKT signaling pathway in depressive model rats
doi 10.3389/fpsyt.2025.1628634
- 1,146 views
ORIGINAL RESEARCH
Published on 15 Aug 2025
Post marketing safety assessment of the novel postpartum depression drug, Zuranolone: evidence from real-world pharmacovigilance analysis based on the FDA adverse event reporting system
doi 10.3389/fpsyt.2025.1517773
- 2,368 views
ORIGINAL RESEARCH
Published on 14 May 2025
Evaluation of drug interactions in outpatients taking antipsychotic medications
doi 10.3389/fphar.2025.1590167
- 2,407 views
BRIEF RESEARCH REPORT
Published on 05 Mar 2025
Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States: the potential effects of evergreening
doi 10.3389/fpsyt.2025.1450111
- 1,484 views
- 1 citation
ORIGINAL RESEARCH
Published on 24 Feb 2025
Post-marketing safety surveillance of vortioxetine hydrobromide: a pharmacovigilance study leveraging FAERS database
doi 10.3389/fpsyt.2025.1532803
- 2,694 views
- 1 citation
CASE REPORT
Published on 07 Nov 2024
Vortioxetine as an alternative treatment for somatic symptom disorder: case report
doi 10.3389/fpsyt.2024.1496072
- 3,512 views
- 3 citations
REVIEW
Published on 25 Sep 2024
Exploring cariprazine as a treatment option for varied depression symptom clusters
doi 10.3389/fpsyt.2024.1442699
- 5,440 views
- 5 citations
Published in
Frontiers in Psychiatry
Psychopharmacology
Mood Disorders
Participating Journals
Frontiers in Pharmacology
- 4.8 impact factor
- 8.9 citescore